Opus Genetics (IRD) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -58.11% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -95.76% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | -699.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -699.79% |
| Dec 31, 2025 | 52.97% |
| Sep 30, 2025 | -131.92% |
| Jun 30, 2025 | 4.44% |
| Mar 31, 2025 | -15.31% |
| Dec 31, 2024 | -632.74% |
| Sep 30, 2024 | -235.34% |
| Jun 30, 2024 | -56.52% |
| Mar 31, 2024 | -22.71% |
| Dec 31, 2023 | -114.13% |
| Sep 30, 2023 | 222.73% |
| Jun 30, 2023 | -0.69% |
| Mar 31, 2023 | 12.19% |
| Dec 31, 2022 | 637.64% |
| Sep 30, 2022 | -7.12% |
| Jun 30, 2022 | 30.96% |
| Mar 31, 2022 | 83.10% |
| Dec 31, 2021 | 66.20% |
| Sep 30, 2021 | -238.94% |
| Jun 30, 2021 | -344.89% |
| Mar 31, 2021 | -1,163.41% |
| Dec 31, 2020 | -3,226.31% |
| Sep 30, 2020 | 36.30% |
| Jun 30, 2020 | 34.91% |
| Mar 31, 2020 | -31.80% |
| Dec 31, 2019 | 119.17% |
| Sep 30, 2019 | 63.30% |
| Jun 30, 2019 | 35.80% |
| Mar 31, 2019 | -12.92% |
| Dec 31, 2018 | 13.25% |
| Sep 30, 2018 | -414.30% |
| Jun 30, 2018 | -505.28% |
| Mar 31, 2018 | 90.40% |
| Dec 31, 2017 | -583.65% |
| Sep 30, 2017 | 63.79% |
| Jun 30, 2017 | 153.63% |
| Mar 31, 2017 | -420.87% |
| Dec 31, 2016 | 81.58% |
| Sep 30, 2016 | 28.80% |
| Jun 30, 2016 | 45.40% |
| Mar 31, 2016 | 2.87% |
| Dec 31, 2015 | -29.05% |
| Sep 30, 2015 | -111.32% |
| Jun 30, 2015 | -1,763.12% |
| Mar 31, 2015 | 70.74% |
| Dec 31, 2014 | 18.74% |
| Sep 30, 2014 | 11.00% |
| Jun 30, 2014 | 106.26% |
| Mar 31, 2014 | -854.22% |
| Dec 31, 2013 | -4,808.79% |
| Sep 30, 2013 | 28.38% |
| Jun 30, 2013 | -198.23% |
| Mar 31, 2013 | 28.49% |
| Dec 31, 2012 | -114.23% |
| Sep 30, 2012 | -103.45% |
| Jun 30, 2012 | 82.12% |
| Mar 31, 2012 | 51.76% |
| Dec 31, 2011 | 114.91% |
| Sep 30, 2011 | -771.21% |
| Jun 30, 2011 | -62.04% |